Clinical Trials Directory

Trials / Completed

CompletedNCT00567814

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction

A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Two Dose Combinations of Metyrapone and Oxazepam in the Treatment of Cocaine Addiction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Embera NeuroTherapeutics, Inc. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Subjects will be randomly assigned to receive either one of the two potential dose combinations of the study medications or placebo over 6 weeks. The study will include twice weekly visits to the research clinic for laboratory studies, safety assessments and urine drug screens. Subjects will also be questioned regarding drug craving and mood symptoms.

Conditions

Interventions

TypeNameDescription
DRUGMetyraponeTwice daily
DRUGOxazepamTwice Daily
DRUGPlaceboTwice daily

Timeline

Start date
2007-12-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2007-12-05
Last updated
2008-12-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00567814. Inclusion in this directory is not an endorsement.

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction (NCT00567814) · Clinical Trials Directory